Switch theme
Sign up to access all valuation multiples
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
2021
1.8K+
LTM Revenue $450M
LTM EBITDA $62.4M
$420M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
ZimVie has a last 12-month revenue of $450M and a last 12-month EBITDA of $62.4M.
In the most recent fiscal year, ZimVie achieved revenue of $450M and an EBITDA of $29.6M.
ZimVie expects next 12-month revenue of XXX and NTM EBITDA of XXX
See ZimVie valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $457M | $450M | XXX | XXX | XXX |
| Gross Profit | $613M | $290M | XXX | XXX | XXX |
| Gross Margin | 134% | 65% | XXX | XXX | XXX |
| EBITDA | $91.1M | $29.6M | XXX | XXX | XXX |
| EBITDA Margin | 20% | 7% | XXX | XXX | XXX |
| Net Profit | -$63.9M | -$393M | XXX | XXX | XXX |
| Net Margin | -14% | -87% | XXX | XXX | XXX |
| Net Debt | $443M | $437M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, ZimVie's stock price is $9.
ZimVie has current market cap of $263M, and EV of $420M.
See ZimVie trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $420M | $263M | XXX | XXX | XXX | XXX | $0.68 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, ZimVie has market cap of $263M and EV of $420M.
ZimVie's trades at 0.9x LTM EV/Revenue multiple, and 6.7x LTM EBITDA.
Analysts estimate ZimVie's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for ZimVie and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $420M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 14.2x | XXX | XXX | XXX |
| P/E | -10.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 56.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpZimVie's NTM/LTM revenue growth is 1%
ZimVie's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, ZimVie's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate ZimVie's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for ZimVie and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -67% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 7% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 64% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ZimVie acquired XXX companies to date.
Last acquisition by ZimVie was XXXXXXXX, XXXXX XXXXX XXXXXX . ZimVie acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was ZimVie founded? | ZimVie was founded in 2021. |
| Where is ZimVie headquartered? | ZimVie is headquartered in United States of America. |
| How many employees does ZimVie have? | As of today, ZimVie has 1.8K+ employees. |
| Who is the CEO of ZimVie? | ZimVie's CEO is Mr. Vafa Jamali. |
| Is ZimVie publicy listed? | Yes, ZimVie is a public company listed on NAS. |
| What is the stock symbol of ZimVie? | ZimVie trades under ZIMV ticker. |
| When did ZimVie go public? | ZimVie went public in 2022. |
| Who are competitors of ZimVie? | Similar companies to ZimVie include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of ZimVie? | ZimVie's current market cap is $263M |
| What is the current revenue of ZimVie? | ZimVie's last 12-month revenue is $450M. |
| What is the current EBITDA of ZimVie? | ZimVie's last 12-month EBITDA is $62.4M. |
| What is the current EV/Revenue multiple of ZimVie? | Current revenue multiple of ZimVie is 0.9x. |
| What is the current EV/EBITDA multiple of ZimVie? | Current EBITDA multiple of ZimVie is 6.7x. |
| What is the current revenue growth of ZimVie? | ZimVie revenue growth between 2023 and 2024 was -2%. |
| Is ZimVie profitable? | Yes, ZimVie is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
